September 1, 2015 - For women undergoing hysterectomy, removal of "hanging" abdominal fat and skin--a cosmetic procedure called panniculectomy--can be performed at the same surgery without increasing the risk of complications, reports a study in the September issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).
"This is among the best evidence to date regarding 30-day risk profiles, and the data suggests that the complication rates are comparable for patients undergoing combined hysterectomy and panniculectomy versus hysterectomy alone," comments lead author Dr. Antonio Jorge Forte. "In other words, patients may elect to benefit from the convenience of multiple procedures in a single stage associated with the peace of mind of documented safety." The research was performed at Yale School of Medicine; Dr. Forte is now at the Mayo Clinic, Jacksonville, Fla.
No Increase in Complications When Adding Panniculectomy to Hysterectomy
Hysterectomy, or removal of the uterus, is among the most common surgical procedures. With the US epidemic of obesity, many women scheduled for hysterectomy are also obese. Dr. Forte explains, "When the obesity is so pronounced that the patient develops a pannus, or 'hanging abdomen,' she may become interested in getting rid of the hanging abdominal skin/fat in addition to the original removal of uterus."
A national surgical database was used to identify more than 25,000 women who underwent hysterectomy between 2005 and 2012. Of these, 174 underwent panniculectomy at the same operation. Thirty-day complication rates were compared for matched groups of women undergoing hysterectomy plus panniculectomy versus hysterectomy alone.
Patients undergoing hysterectomy plus panniculectomy were more likely to be obese, to have diabetes, and to have a history of heart or lung disease. Median surgical time was twice as long in the combined surgery group: about four hours, compared to two hours for hysterectomy alone.
Overall, women undergoing hysterectomy plus panniculectomy had a higher rate of blood clot-related complications called venous thromboembolism (VTE): three percent versus one percent. Women in the combined group were also more likely to stay in the hospital for three days or longer: 48 percent versus 29 percent.
But when comparing the matched groups of patients with similar characteristics, the researchers found no significant difference in VTE risk. There was also no difference in wound complications, surgical site infections, medical complications, or total complication rate.
"The significant differences in complications initially identified in our unadjusted analysis were not found after matching patients from both groups," Dr. Forte emphasizes. "This highlights the critical importance of patient selection for avoiding complications in combined procedures."
However, the difference in length of hospital stay remained significant. Women undergoing hysterectomy plus panniculectomy were twice as likely to spend at least three days in the hospital.
At some hospitals, plastic and gynecological surgical procedures are commonly performed together. But some surgeons may be concerned that performing panniculectomy and hysterectomy together might increase the risk of complications. Few previous studies have evaluated the safety of this combination of procedures.
The new study supports the safety of this combined approach. "Our study indicates that there is a similar complication rate between women who chose to undergo a combined panniculectomy and hysterectomy as compared to those who had hysterectomy alone," says Dr. Forte. "However, these patients should be counseled to expect to stay longer in the hospital after combined procedures."
"Our findings do not end the conversation about risks associated with combined procedures, but provide more data to help patients and providers make informed decisions," Dr. Forte adds.
Article: "Hysterectomy with Concurrent Panniculectomy: A Propensity-Matched Analysis of 30-Day Outcomes" (doi: 10.1097/PRS.0000000000001535)
About Plastic and Reconstructive Surgery
For more than 60 years, Plastic and Reconstructive Surgery® has been the one consistently excellent reference for every specialist who uses plastic surgery techniques or works in conjunction with a plastic surgeon. The official journal of the American Society of Plastic Surgeons, Plastic and Reconstructive Surgery® brings subscribers up-to-the-minute reports on the latest techniques and follow-up for all areas of plastic and reconstructive surgery, including breast reconstruction, experimental studies, maxillofacial reconstruction, hand and microsurgery, burn repair, and cosmetic surgery, as well as news on medico-legal issues.
The American Society of Plastic Surgeons (ASPS) is the world's largest organization of board-certified plastic surgeons. Representing more than 7,000 Member Surgeons, the Society is recognized as a leading authority and information source on aesthetic and reconstructive plastic surgery. ASPS comprises more than 94 percent of all board-certified plastic surgeons in the United States. Founded in 1931, the Society represents physicians certified by The American Board of Plastic Surgery or The Royal College of Physicians and Surgeons of Canada. ASPS advances quality care to plastic surgery patients by encouraging high standards of training, ethics, physician practice and research in plastic surgery. You can learn more and visit the American Society of Plastic Surgeons at http://www.
About Wolters Kluwer
Wolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer's market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.
Wolters Kluwer reported 2014 annual revenues of €3.7 billion. The group serves customers in over 170 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on NYSE Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and organization, visit http://www.